文献速递认知障碍与痴呆帕金森病与运动障碍癫痫

临床前动物研究统计方法与设计同二期临床试验转化成功之间的关联

Association of Statistical Methodology and Design in Preclinical Animal Studies With Successful Translation Into Clinical Phase 2 Trials.
PubMed 文献 · Neurology · 2025-10-13

该研究采用改良荟萃研究、病例对照设计,针对多发性硬化、帕金森病和癫痫3种神经适应证,比较阳性与阴性二期临床试验前动物实验的统计错误率。结果显示,阴性试验前的动物研究更常出现横断面统计方法误用于纵向数据(93% vs 66%)及掩盖连续数据分布的图表(98% vs 71%)。提示转化决策应评估临床前统计实践质量。

要点

  • 阴性二期临床试验前的动物研究统计错误率更高
  • 横断面检验误用于纵向数据:阴性试验前93%,阳性试验前66%
  • 掩盖连续数据分布的图表使用率:阴性试验前98%,阳性试验前71%

核心结论

  • 临床前动物研究的统计实践普遍较差或报告不充分,部分统计错误在阴性临床试验前更常见。
  • 转化决策应纳入对临床前统计实践质量的评估。

研究设计与样本

  • 采用改良荟萃研究、病例对照设计,通过多步系统检索识别2010年1月1日至2020年10月31日完成的二期临床试验。
  • 最终样本包括24项临床试验(其中8项阴性)和70项相关啮齿类动物研究。

主要发现

  • 阴性人体试验前的动物研究将仅横断面统计检验误用于纵向数据的比例为93%(95%CI 83-100),阳性试验前为66%(95%CI 47-82)。
  • 阴性人体试验前的动物研究使用掩盖连续数据分布的图表比例为98%(95%CI 95-100),阳性试验前为71%(95%CI 51-91)。

临床怎么用

  • 在评估新干预措施是否进入临床转化时,应同时审查支持性临床前动物研究的统计方法适当性和报告质量。

局限性

  • 本研究为探索性研究,样本经过高度选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Preclinical-to-clinical translational failure is common in neurologic research. Reasons for translational failure are complex and multifaceted, but it is increasingly recognized that translational decision making may be influenced by preclinical work that is overly optimistic, due to a lack of scientific rigor. Previous research has demonstrated that statistical errors are common in preclinical research, yet results of preclinical null hypothesis significance testing contribute to the body of evidence used to evaluate whether a new intervention is a candidate for translation. However, no empirical investigations exist yet that compare positive and negative clinical trials on the statistical soundness of contributing studies. The aim of this study was to explore, for 3 neurologic indications (multiple sclerosis, Parkinson disease, epilepsy), whether negative clinical trials show a higher prevalence of statistical misapplication in preceding animal experiments, compared with positive human trials. METHODS: A modified meta-research, case-control design with multistep systematic search was used. Phase 2 clinical trials (completed January 1, 2010-October 31, 2020) were identified on ClinicalTrials.gov. Best practice methods were used to systematically search MEDLINE and Embase for animal experiments preceding the start of each human trial, for each intervention and disease. Statistical reporting and decision-making data were gathered from animal articles by collectors blinded to human trial outcome. Rates of statistical mistakes were compared between animal articles preceding positive vs negative human trials using weighted percentages and CIs. RESULTS: The final sample included 24 trials (8 negative) and 70 associated rodent studies. Animal studies preceding negative human trials had higher rates of misapplication of solely cross-sectional statistical tests to longitudinal data (93% [95% CI 83-100] vs 66% [95% CI 47-82]) and of the use of plots that concealed continuous data distributions (98% [95% CI 95-100] vs 71% [95% CI 51-91]), indicating possible mishandling of continuous data. DISCUSSION: Statistical practice in animal studies was generally poor or not well reported, with rates of some statistical mistakes occurring more frequently before negative trials than positive trials. This was an exploratory study with a highly selected sample, yet it suggests that translational decision making should include evaluation of the quality of preclinical statistical practice.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Hogue O, Zelinsky M, Sonneborn C, et al. Association of Statistical Methodology and Design in Preclinical Animal Studies With Successful Translation Into Clinical Phase 2 Trials. Neurology. 2025. PMID: 41082697. doi:10.1212/WNL.0000000000214250

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。